Webinar: Patient Assistance in the Wake of COVID19

By Lash Group |

As the U.S. economy continues to feel the ripple effect of the coronavirus pandemic and more Americans lose their jobs, will patients be able to afford their medications?

It’s a question that matters across therapeutic areas and one that will impact manufacturers’ commercialization strategies, especially as it relates to patient and provider support. 

Watch a panel of experts from Lash Group and Xcenda as they offer insights on:

  • How the COVID-19 pandemic will impact insurance coverage
  • The resulting affordability challenges patients will face
  • How manufacturers can adapt their patient assistance programs to ensure access to important therapies

Lash Group Experts

Mark Beightol
Vice President, Client Delivery
Fort Mill, SC
Nicole Dunn
Vice President, Client Delivery
Fort Mill, SC
Rose Herring
Director, Marketing
Fort Mill, SC
Jack McGuire, Pharm.D., MBA, CNMT
Vice President, Pharmacy Services
Brooks, KY

Xcenda Experts

Corey Ford Corey Ford, MHA
Director, Reimbursement & Policy Insights
Melissa Mulchahey
Vice President, Field Services Client Engagement and Business Development